We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
+$224M
Cap. Flow %
177.31%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.82M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.47M
3
IBB icon
iShares Biotechnology ETF
IBB
+$2M
4
ULTA icon
Ulta Beauty
ULTA
+$1.86M
5
MON
Monsanto Co
MON
+$1.82M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 39.95%
2 Consumer Staples 5.72%
3 Consumer Discretionary 5.14%
4 Technology 3.35%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNDT
276
DELISTED
Mandiant, Inc. Common Stock
MNDT
$19K 0.02%
1,293
– –
CI icon
277
PUT
Cigna
CI
$74.5B
$18K 0.01%
600
– –
M icon
278
PUT
Macy's
M
$6.23B
$18K 0.01%
12,500
– –
INSY
279
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
$18K 0.01%
+20,000
New +$304K
WOLF icon
280
PUT
Wolfspeed
WOLF
$1.55B
$17K 0.01%
+12,000
New +$310K
SFLY
281
CALL
DELISTED
Shutterfly, Inc.
SFLY
$17K 0.01%
+15,000
New +$744K
CXRX
282
PUT
DELISTED
Concordia International Corp. Common Stock
CXRX
$17K 0.01%
21,000
+3,500
+20% +$43.9K
ABBV icon
283
CALL
AbbVie
ABBV
$450B
$16K 0.01%
38,844
– –
CL icon
284
PUT
Colgate-Palmolive
CL
$74.4B
$16K 0.01%
2,500
+500
+25% +$37K
SPLK
285
CALL
DELISTED
Splunk Inc
SPLK
$16K 0.01%
22,800
-3,300
-13% -$198K
KO icon
286
CALL
Coca-Cola
KO
$351B
$15K 0.01%
251,200
+70,300
+39% +$3.08M
MRSH
287
CALL
Marsh
MRSH
$87.8B
$15K 0.01%
+27,500
New +$1.84M
LUMO
288
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$14K 0.01%
5,611
-3,311
-37% -$329K
ENDP
289
CALL
DELISTED
Endo International plc
ENDP
$14K 0.01%
10,000
– –
ASML icon
290
PUT
ASML
ASML
$671B
$13K 0.01%
14,200
+4,500
+46% +$476K
QCOM icon
291
CALL
Qualcomm
QCOM
$181B
$13K 0.01%
3,200
-1,800
-36% -$109K
A icon
292
PUT
Agilent Technologies
A
$37.1B
$12K 0.01%
+15,000
New +$700K
ALNY icon
293
PUT
Alnylam Pharmaceuticals
ALNY
$35.7B
$12K 0.01%
30,000
– –
CYBR
294
CALL
DELISTED
CyberArk
CYBR
$12K 0.01%
28,200
+3,300
+13% +$176K
WOLF icon
295
CALL
Wolfspeed
WOLF
$1.55B
$12K 0.01%
+8,900
New +$230K
HRTX icon
296
CALL
Heron Therapeutics
HRTX
$89.1M
$11K 0.01%
32,200
+12,000
+59% +$223K
HSY icon
297
PUT
Hershey
HSY
$34.8B
$11K 0.01%
4,800
+600
+14% +$63.5K
SBUX icon
298
CALL
Starbucks
SBUX
$120B
$11K 0.01%
+12,500
New +$699K
LXK
299
CALL
DELISTED
Lexmark Intl Inc
LXK
$11K 0.01%
+2,000
New +$72.7K
NKE icon
300
Nike
NKE
$64.9B
$10K 0.01%
+184
New +$10.4K
10 11
12
13 14

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.